Activation of the Syk tyrosine kinase is insufficient for downstream signal transduction in B lymphocytes.

Robert C. Hsueh, Adrienne M. Hammill, Jamie A. Lee, Jonathan W. Uhr, Richard H. Scheuermann

Research output: Contribution to journalArticle

Abstract

BACKGROUND: Immature B lymphocytes and certain B cell lymphomas undergo apoptotic cell death following activation of the B cell antigen receptor (BCR) signal transduction pathway. Several biochemical changes occur in response to BCR engagement, including activation of the Syk tyrosine kinase. Although Syk activation appears to be necessary for some downstream biochemical and cellular responses, the signaling events that precede Syk activation remain ill defined. In addition, the requirements for complete activation of the Syk-dependent signaling step remain to be elucidated. RESULTS: A mutant form of Syk carrying a combination of a K395A substitution in the kinase domain and substitutions of three phenylalanines (3F) for the three C-terminal tyrosines was expressed in a murine B cell lymphoma cell line, BCL1.3B3 to interfere with normal Syk regulation as a means to examine the Syk activation step in BCR signaling. Introduction of this kinase-inactive mutant led to the constitutive activation of the endogenous wildtype Syk enzyme in the absence of receptor engagement through a 'dominant-positive' effect. Under these conditions, Syk kinase activation occurred in the absence of phosphorylation on Syk tyrosine residues. Although Syk appears to be required for BCR-induced apoptosis in several systems, no increase in spontaneous cell death was observed in these cells. Surprisingly, although the endogenous Syk kinase was enzymatically active, no enhancement in the phosphorylation of cytoplasmic proteins, including phospholipase Cgamma2 (PLCgamma2), a direct Syk target, was observed. CONCLUSION: These data indicate that activation of Syk kinase enzymatic activity is insufficient for Syk-dependent signal transduction. This observation suggests that other events are required for efficient signaling. We speculate that localization of the active enzyme to a receptor complex specifically assembled for signal transduction may be the missing event.

Original languageEnglish (US)
Pages (from-to)16
Number of pages1
JournalBMC immunology [electronic resource]
Volume3
Issue number1
StatePublished - Dec 6 2002

Fingerprint

B-Cell Antigen Receptors
Protein-Tyrosine Kinases
Signal Transduction
B-Lymphocytes
B-Cell Lymphoma
Tyrosine
Cell Death
Phosphotransferases
Phosphorylation
B-Lymphoid Precursor Cells
Phospholipases
Enzymes
Phenylalanine
Apoptosis
Cell Line
Syk Kinase
Proteins

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Hsueh, R. C., Hammill, A. M., Lee, J. A., Uhr, J. W., & Scheuermann, R. H. (2002). Activation of the Syk tyrosine kinase is insufficient for downstream signal transduction in B lymphocytes. BMC immunology [electronic resource], 3(1), 16.

Activation of the Syk tyrosine kinase is insufficient for downstream signal transduction in B lymphocytes. / Hsueh, Robert C.; Hammill, Adrienne M.; Lee, Jamie A.; Uhr, Jonathan W.; Scheuermann, Richard H.

In: BMC immunology [electronic resource], Vol. 3, No. 1, 06.12.2002, p. 16.

Research output: Contribution to journalArticle

Hsueh, Robert C. ; Hammill, Adrienne M. ; Lee, Jamie A. ; Uhr, Jonathan W. ; Scheuermann, Richard H. / Activation of the Syk tyrosine kinase is insufficient for downstream signal transduction in B lymphocytes. In: BMC immunology [electronic resource]. 2002 ; Vol. 3, No. 1. pp. 16.
@article{e3f79eb85aee4407a1d372adf0401f4a,
title = "Activation of the Syk tyrosine kinase is insufficient for downstream signal transduction in B lymphocytes.",
abstract = "BACKGROUND: Immature B lymphocytes and certain B cell lymphomas undergo apoptotic cell death following activation of the B cell antigen receptor (BCR) signal transduction pathway. Several biochemical changes occur in response to BCR engagement, including activation of the Syk tyrosine kinase. Although Syk activation appears to be necessary for some downstream biochemical and cellular responses, the signaling events that precede Syk activation remain ill defined. In addition, the requirements for complete activation of the Syk-dependent signaling step remain to be elucidated. RESULTS: A mutant form of Syk carrying a combination of a K395A substitution in the kinase domain and substitutions of three phenylalanines (3F) for the three C-terminal tyrosines was expressed in a murine B cell lymphoma cell line, BCL1.3B3 to interfere with normal Syk regulation as a means to examine the Syk activation step in BCR signaling. Introduction of this kinase-inactive mutant led to the constitutive activation of the endogenous wildtype Syk enzyme in the absence of receptor engagement through a 'dominant-positive' effect. Under these conditions, Syk kinase activation occurred in the absence of phosphorylation on Syk tyrosine residues. Although Syk appears to be required for BCR-induced apoptosis in several systems, no increase in spontaneous cell death was observed in these cells. Surprisingly, although the endogenous Syk kinase was enzymatically active, no enhancement in the phosphorylation of cytoplasmic proteins, including phospholipase Cgamma2 (PLCgamma2), a direct Syk target, was observed. CONCLUSION: These data indicate that activation of Syk kinase enzymatic activity is insufficient for Syk-dependent signal transduction. This observation suggests that other events are required for efficient signaling. We speculate that localization of the active enzyme to a receptor complex specifically assembled for signal transduction may be the missing event.",
author = "Hsueh, {Robert C.} and Hammill, {Adrienne M.} and Lee, {Jamie A.} and Uhr, {Jonathan W.} and Scheuermann, {Richard H.}",
year = "2002",
month = "12",
day = "6",
language = "English (US)",
volume = "3",
pages = "16",
journal = "BMC Immunology",
issn = "1471-2172",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Activation of the Syk tyrosine kinase is insufficient for downstream signal transduction in B lymphocytes.

AU - Hsueh, Robert C.

AU - Hammill, Adrienne M.

AU - Lee, Jamie A.

AU - Uhr, Jonathan W.

AU - Scheuermann, Richard H.

PY - 2002/12/6

Y1 - 2002/12/6

N2 - BACKGROUND: Immature B lymphocytes and certain B cell lymphomas undergo apoptotic cell death following activation of the B cell antigen receptor (BCR) signal transduction pathway. Several biochemical changes occur in response to BCR engagement, including activation of the Syk tyrosine kinase. Although Syk activation appears to be necessary for some downstream biochemical and cellular responses, the signaling events that precede Syk activation remain ill defined. In addition, the requirements for complete activation of the Syk-dependent signaling step remain to be elucidated. RESULTS: A mutant form of Syk carrying a combination of a K395A substitution in the kinase domain and substitutions of three phenylalanines (3F) for the three C-terminal tyrosines was expressed in a murine B cell lymphoma cell line, BCL1.3B3 to interfere with normal Syk regulation as a means to examine the Syk activation step in BCR signaling. Introduction of this kinase-inactive mutant led to the constitutive activation of the endogenous wildtype Syk enzyme in the absence of receptor engagement through a 'dominant-positive' effect. Under these conditions, Syk kinase activation occurred in the absence of phosphorylation on Syk tyrosine residues. Although Syk appears to be required for BCR-induced apoptosis in several systems, no increase in spontaneous cell death was observed in these cells. Surprisingly, although the endogenous Syk kinase was enzymatically active, no enhancement in the phosphorylation of cytoplasmic proteins, including phospholipase Cgamma2 (PLCgamma2), a direct Syk target, was observed. CONCLUSION: These data indicate that activation of Syk kinase enzymatic activity is insufficient for Syk-dependent signal transduction. This observation suggests that other events are required for efficient signaling. We speculate that localization of the active enzyme to a receptor complex specifically assembled for signal transduction may be the missing event.

AB - BACKGROUND: Immature B lymphocytes and certain B cell lymphomas undergo apoptotic cell death following activation of the B cell antigen receptor (BCR) signal transduction pathway. Several biochemical changes occur in response to BCR engagement, including activation of the Syk tyrosine kinase. Although Syk activation appears to be necessary for some downstream biochemical and cellular responses, the signaling events that precede Syk activation remain ill defined. In addition, the requirements for complete activation of the Syk-dependent signaling step remain to be elucidated. RESULTS: A mutant form of Syk carrying a combination of a K395A substitution in the kinase domain and substitutions of three phenylalanines (3F) for the three C-terminal tyrosines was expressed in a murine B cell lymphoma cell line, BCL1.3B3 to interfere with normal Syk regulation as a means to examine the Syk activation step in BCR signaling. Introduction of this kinase-inactive mutant led to the constitutive activation of the endogenous wildtype Syk enzyme in the absence of receptor engagement through a 'dominant-positive' effect. Under these conditions, Syk kinase activation occurred in the absence of phosphorylation on Syk tyrosine residues. Although Syk appears to be required for BCR-induced apoptosis in several systems, no increase in spontaneous cell death was observed in these cells. Surprisingly, although the endogenous Syk kinase was enzymatically active, no enhancement in the phosphorylation of cytoplasmic proteins, including phospholipase Cgamma2 (PLCgamma2), a direct Syk target, was observed. CONCLUSION: These data indicate that activation of Syk kinase enzymatic activity is insufficient for Syk-dependent signal transduction. This observation suggests that other events are required for efficient signaling. We speculate that localization of the active enzyme to a receptor complex specifically assembled for signal transduction may be the missing event.

UR - http://www.scopus.com/inward/record.url?scp=0642303857&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0642303857&partnerID=8YFLogxK

M3 - Article

C2 - 12470302

VL - 3

SP - 16

JO - BMC Immunology

JF - BMC Immunology

SN - 1471-2172

IS - 1

ER -